| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||




From the * Department of Microbiology and Research
Laboratory "Microorganismes et Pathologie Humaine," Habib
Bourguiba Hospital, Sfax, Tunisia;
and the
Laboratory of Histology-Embryology and Biology of Reproduction, Medical
School, Sfax, Tunisia.
| Correspondence to: Dr R. Gdoura or Prof A. Hammami, Laboratory of Microbiology, Faculté de Médecine de Sfax, Avenue Magida Boulila, 3029, Sfax, Tunisia (e-mail: gdourar{at}yahoo.com) (Dr Gdoura) (e-mail: Adnene.hammami{at}rns.tn) (Prof Hammami). |
> 0.9) between the detection of Chlamydia
trachomatis, genital ureaplasmas, and Mycoplasma hominis in
semen and corresponding FVU specimens. Our findings also show a high
concordance (81.1%) and a good agreement (
= 0.79) between the
detection of Mycoplasma genitalium in both specimens. C
trachomatis, genital mycoplasmas, and genital ureaplasmas were found to
be widespread among infertile male patients in Tunisia, as shown by their
respective prevalences of 43.3%, 18.3%, and 14.4%. The mean values of seminal
volume, sperm concentration, sperm viability, sperm motility, sperm
morphology, and leukocyte count were not significantly related either to the
detection of C trachomatis DNA or to that of genital ureaplasma or
mycoplasma DNA in semen specimens. Using our in-house PCR, both semen and FVU
were found to be sensitive diagnostic specimens for the detection of C
trachomatis, ureaplasmas, and mycoplasmas. The FVU, a less invasive and
self-collected specimen, can serve as a marker for the presence of these
organisms in the genital tract and can be used as a reliable way of detecting
asymptomatic carriers of infection.
Key words: Male infertility, sperm quality
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |